Aptevo Therapeutics Letter of Support
Aptevo Therapeutics has released a letter in support of the 340B Program. Click here to read it.
Octapharma Letter of Support
Octapharma has released a letter in support of the 340B Program. Click here to read it.
Letters of Support
The Hemophilia Alliance recently received letters of support from Baxter Healthcare Corporation, CSL Behring, National Hemophilia Foundation and Octapharma A.G. Aptevo : Click here to view the letter as a PDF. Baxter Healthcare Corporation : Click here to view the letter as a PDF. Biogen Idec: Click here to view the letter as a PDF. […]
CSL News Release, May 2009
CSL, a maker of blood-plasma products, said the Federal Trade Commission recommended legal action to block the proposed $3.1 billion purchase of Talecris Bio- therapeutics Holdings.